| 251 |
21835258 | The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function. | 2012 Jan |
2 |
| 252 |
21847707 | The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway. | 2012 Jan |
2 |
| 253 |
21940785 | Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial. | 2012 May |
1 |
| 254 |
21983014 | Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1. | 2012 Feb |
1 |
| 255 |
22159752 | COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines. | 2012 Jul |
5 |
| 256 |
22187234 | Effects of combination therapy with celecoxib and doxycycline on neointimal hyperplasia and inflammatory biomarkers in coronary artery disease patients treated with bare metal stents. | 2012 Jan |
1 |
| 257 |
22262921 | Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis. | 2012 Apr |
1 |
| 258 |
22366264 | Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells. | 2012 Apr 15 |
1 |
| 259 |
22415852 | Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. | 2012 Jul |
1 |
| 260 |
22632102 | Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis. | 2012 Jul |
2 |
| 261 |
22735362 | Renal effects of high-dose celecoxib in elderly men with stage D2 prostate carcinoma. | 2012 Nov |
1 |
| 262 |
22890064 | Colorectal polyps in childhood. | 2012 Oct |
1 |
| 263 |
22891999 | Activation of diverse eicosanoid pathways in osteoarthritic cartilage: a lipidomic and genomic analysis. | 2012 |
1 |
| 264 |
22898640 | The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. | 2012 Jul-Aug |
1 |
| 265 |
22934397 | [Observation on curative effect of thermal acupuncture needle muscular stimulation therapy for knee osteoarthritis patients]. | 2012 Jun |
1 |
| 266 |
23036953 | Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents. | 2012 Nov 1 |
1 |
| 267 |
23114124 | [Effects of COX-2 inhibitor celecoxib on expressions of VEGF, b-FGF and TGF-β mRNA in acute leukemia cells]. | 2012 Oct |
2 |
| 268 |
23174742 | Three concerns with regards to the utilization of COX-2 inhibitor (celecoxib) in combination with standard chemoradiotherapy for nasopharyngeal carcinoma. | 2012 Jul-Sep |
1 |
| 269 |
23249419 | Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo. | 2012 Dec 19 |
2 |
| 270 |
23394447 | Change in nicotine-induced VEGF, PGE2 AND COX-2 expression following COX inhibition in human oral squamous cancer. | 2012 |
2 |
| 271 |
23552603 | COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP. | 2012 Apr 2 |
1 |
| 272 |
28520369 | Celecoxib Therapy and CYP2C9 Genotype | 2012 |
1 |
| 273 |
20817448 | Measurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry. | 2011 Jan 5 |
2 |
| 274 |
20880055 | Effects of celecoxib on major prostaglandins in asthma. | 2011 Jan |
1 |
| 275 |
20974686 | Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E₂ and prostaglandin E₂ receptors. | 2011 Jan |
1 |
| 276 |
21084865 | Induction of a fast inactivation gating on delayed rectifier Shab K(+) channels by the anti-inflammatory drug celecoxib. | 2011 Jan-Feb |
1 |
| 277 |
21113620 | The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study. | 2011 Jun |
1 |
| 278 |
21140284 | Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines. | 2011 Apr |
2 |
| 279 |
21220497 | Celecoxib can induce vascular endothelial growth factor expression and tumor angiogenesis. | 2011 Jan |
1 |
| 280 |
21488638 | Divergent C-H functionalizations directed by sulfonamide pharmacophores: late-stage diversification as a tool for drug discovery. | 2011 May 11 |
1 |
| 281 |
21540248 | Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway. | 2011 May 1 |
3 |
| 282 |
21546775 | Gene expression following exposure to celecoxib in humans: pathways of inflammation and carcinogenesis are activated in tumors but not normal tissues. | 2011 |
1 |
| 283 |
21548865 | Lipoxins, the novel mediators of gastroprotection and gastric adaptation to ulcerogenic action of aspirin. | 2011 |
2 |
| 284 |
21567098 | Celecoxib induces cell apoptosis coupled with up-regulation of the expression of VEGF by a mechanism involving ER stress in human colorectal cancer cells. | 2011 Aug |
3 |
| 285 |
21627839 | Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. | 2011 May 31 |
1 |
| 286 |
21688615 | [Low-dose aspirin (LDA)/nonsteroidal anti-inflammatory drugs(NSAIDs)-induced gastrointestinal injury in Japan]. | 2011 Jun |
1 |
| 287 |
21729671 | Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer. | 2011 Aug |
1 |
| 288 |
21738696 | Grape seed proanthocyanidins inhibit melanoma cell invasiveness by reduction of PGE2 synthesis and reversal of epithelial-to-mesenchymal transition. | 2011 |
1 |
| 289 |
21763744 | COX-2 regulates the proliferation of glioma stem like cells. | 2011 Oct |
1 |
| 290 |
21778329 | Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. | 2011 Nov |
1 |
| 291 |
21796157 | Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms. | 2011 Jul 28 |
2 |
| 292 |
21807123 | The acid sphingomyelinase inhibitors block interferon-α-induced serotonin uptake via a COX-2/Akt/ERK/STAT-dependent pathway in T cells. | 2011 Nov |
2 |
| 293 |
21826992 | [Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/ Taxol) and explore its underlying mechanism]. | 2011 May |
1 |
| 294 |
21868755 | Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3. | 2011 Oct 1 |
1 |
| 295 |
21886896 | Design, synthesis and biological evaluation of new 5,5-diarylhydantoin derivatives as selective cyclooxygenase-2 inhibitors. | 2011 Jul-Sep |
1 |
| 296 |
21896649 | Boxing bladder cancer with COX-2-specific inhibition. | 2011 Oct |
1 |
| 297 |
21936449 | COX-2 inhibitor, celecoxib, may prevent lung cancer. | 2011 Aug |
1 |
| 298 |
21946257 | Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. | 2011 Oct |
1 |
| 299 |
21955617 | Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. | 2011 |
3 |
| 300 |
21993002 | Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors. | 2011 Oct |
1 |